Literature DB >> 15074454

Exercise training in chronic obstructive pulmonary disease.

Carolyn L Rochester1.   

Abstract

Exercise and activity limitation are characteristic features of chronic obstructive pulmonary disease (COPD). Exercise intolerance may result from ventilatory limitation, cardiovascular impairment, and/or skeletal muscle dysfunction. Exercise training, a core component of pulmonary rehabilitation, improves the exercise capacity (endurance and, to a lesser degree, maximal work capacity) of patients with COPD in spite of the irreversible abnormalities in lung function. Dyspnea and health-related quality of life also improve following pulmonary rehabilitation. The clinical benefits of exercise rehabilitation last up to 2 years following 8 to 12 weeks of training. Existing evidence-based guidelines recommend that exercise training/pulmonary rehabilitation be included routinely in the management of patients with moderate to severe COPD. Exercise training/ pulmonary rehabilitation may be undertaken in an inpatient, outpatient, or home-based setting, depending on the individual needs of the patient and available resources. The type and intensity of training and muscle groups trained determine the expected outcomes of exercise training. Both high- and low-intensity exercise lead to increased exercise endurance, but only high-intensity training also leads to physiologic gains in aerobic fitness. The rationale for and outcomes of lower- and upper-limb training, as well as ventilatory muscle training, are reviewed, and the potential for anabolic hormone supplementation to optimize the benefits of exercise training is discussed.

Entities:  

Mesh:

Year:  2003        PMID: 15074454     DOI: 10.1682/jrrd.2003.10.0059

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  10 in total

1.  Effect of upper extremity exercise in people with COPD.

Authors:  Ganesan Kathiresan; Senthil Kumar Jeyaraman; Jayachandran Jaganathan
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

2.  Extrinsic Threshold PEEP Reduces Post-exercise Dyspnea in COPD Patients: A Placebo-controlled, Double-blind Cross-over Study.

Authors:  A Daniel Martin; Paul W Davenport
Journal:  Cardiopulm Phys Ther J       Date:  2011-09

3.  Plasma inflammatory biomarkers response to aerobic versus resisted exercise training for chronic obstructive pulmonary disease patients.

Authors:  Shehab M Abd El-Kader; Osama H Al-Jiffri; Fadwa M Al-Shreef
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

4.  Telehealth Pulmonary Rehabilitation for Patients With Severe Chronic Obstructive Pulmonary Disease.

Authors:  Mon S Bryant; Venkata D Bandi; Christina K Nguyen; Charlie Lan; Helene K Henson; Amir Sharafkhaneh
Journal:  Fed Pract       Date:  2019-09

5.  Investigating activity in hospitalized patients with chronic obstructive pulmonary disease: a pilot study.

Authors:  Chris Winkelman
Journal:  Heart Lung       Date:  2010-04-08       Impact factor: 2.210

Review 6.  Differential assessment and management of asthma vs chronic obstructive pulmonary disease.

Authors:  Barbara P Yawn
Journal:  Medscape J Med       Date:  2009-01-21

Review 7.  A review of cognitive behavioral therapy for panic disorder in patients with chronic obstructive pulmonary disease: the rationale for interoceptive exposure.

Authors:  Terri L Barrera; Kathleen M Grubbs; Mark E Kunik; Ellen J Teng
Journal:  J Clin Psychol Med Settings       Date:  2014-06

Review 8.  Oxygen therapy during exercise training in chronic obstructive pulmonary disease.

Authors:  M L Nonoyama; D Brooks; Y Lacasse; G H Guyatt; R S Goldstein
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

9.  Physical activity targeted at maximal lipid oxidation: a meta-analysis.

Authors:  A J Romain; M Carayol; M Desplan; C Fedou; G Ninot; J Mercier; A Avignon; J F Brun
Journal:  J Nutr Metab       Date:  2012-08-14

10.  Costs and benefits of pulmonary rehabilitation in chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  Catharinne C Farias; Vanessa Resqueti; Fernando A L Dias; Audrey Borghi-Silva; Ross Arena; Guilherme A F Fregonezi
Journal:  Braz J Phys Ther       Date:  2014-05-02       Impact factor: 3.377

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.